CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused…
Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…
FRANKFURT, Germany, May 29, 2025 /PRNewswire/ -- Qualifyze, already the global leader in third-party audit services for the pharmaceutical industry,…
Total Revenues of $759.0M, up 17% Year Over YearSubscription Services Revenues of $634.8M, up 19% Year Over Year PLEASANTON, Calif.,…
Toronto, Ontario--(Newsfile Corp. - May 28, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical…
Global Healthcare Company Expands Digital Health Innovation to Simplify and Secure Cross-border Pet Travel VOORHEES, N.J., May 28, 2025 /PRNewswire/…
CARY, N.C., May 28, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical…
BILLERICA, Mass. and FREISING, Germany, May 28, 2025 /PRNewswire/ -- Momentum Biotechnologies ("Momentum"), a contract research organization specializing in mass spectrometry-based drug…
First-of-its-kind quality improvement initiative, Project EVEREST, is backed by Daiichi Sankyo, Genentech, and AstraZeneca. NEW YORK, May 28, 2025 /PRNewswire/…
Provides high-precision LC column connectivity to achieve consistent chromatography results TORRANCE, Calif., May 28, 2025 /PRNewswire/ -- Phenomenex Inc., a…